C4 Therapeutics Appoints Kendra Adams As CFO, Effective September 18, 2023
Portfolio Pulse from Benzinga Newsdesk
C4 Therapeutics has announced the appointment of Kendra Adams as CFO, effective from September 18, 2023. The current CFO, Lauren White, will be leaving the company to pursue a new role with a commercial-stage pharmaceutical company.
September 05, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
C4 Therapeutics (CCCC) will see a change in its CFO position with Kendra Adams taking over from Lauren White on September 18, 2023.
Changes in key management positions can have an impact on a company's operations and strategy. However, it's unclear at this point how this change will affect C4 Therapeutics' financial performance or stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100